IMIDAZOPYRIDAZINE IL-17 INHIBITOR COMPOUNDS
The present application discloses compounds having the following formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, and R4 are defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediate...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | VALDES, Alexander E VENABLE, Jennifer D MCCARVER, Stefan BEHENNA, Douglas C HANNA, Luke E GORDON, Deane GOLDBERG, Steven D WU, Dongpei LOSKOT, Steven A SHIREMAN, Brock T MEDUNA, Steven P XUE, Xiaohua |
| description | The present application discloses compounds having the following formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, and R4 are defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.
La présente invention concerne des composés ayant la formule suivante (I) : ou des sels pharmaceutiquement acceptables de ceux-ci, R1, R2, R3 et R4 étant tels que définis dans la description, ainsi que des procédés de fabrication et d'utilisation des composés de l'invention pour traiter ou soulager un syndrome, un trouble et/ou une maladie à médiation par IL-17. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023049886A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023049886A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023049886A13</originalsourceid><addsrcrecordid>eNrjZND29PV0cYzyD4gMAtGefq4Knj66huYKnn4enk6eIf5BCs7-vgH-oX4uwTwMrGmJOcWpvFCam0HZzTXE2UM3tSA_PrW4IDE5NS-1JD7c38jAyNjAxNLCwszR0Jg4VQAZ6yYM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IMIDAZOPYRIDAZINE IL-17 INHIBITOR COMPOUNDS</title><source>esp@cenet</source><creator>VALDES, Alexander E ; VENABLE, Jennifer D ; MCCARVER, Stefan ; BEHENNA, Douglas C ; HANNA, Luke E ; GORDON, Deane ; GOLDBERG, Steven D ; WU, Dongpei ; LOSKOT, Steven A ; SHIREMAN, Brock T ; MEDUNA, Steven P ; XUE, Xiaohua</creator><creatorcontrib>VALDES, Alexander E ; VENABLE, Jennifer D ; MCCARVER, Stefan ; BEHENNA, Douglas C ; HANNA, Luke E ; GORDON, Deane ; GOLDBERG, Steven D ; WU, Dongpei ; LOSKOT, Steven A ; SHIREMAN, Brock T ; MEDUNA, Steven P ; XUE, Xiaohua</creatorcontrib><description>The present application discloses compounds having the following formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, and R4 are defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.
La présente invention concerne des composés ayant la formule suivante (I) : ou des sels pharmaceutiquement acceptables de ceux-ci, R1, R2, R3 et R4 étant tels que définis dans la description, ainsi que des procédés de fabrication et d'utilisation des composés de l'invention pour traiter ou soulager un syndrome, un trouble et/ou une maladie à médiation par IL-17.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230330&DB=EPODOC&CC=WO&NR=2023049886A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230330&DB=EPODOC&CC=WO&NR=2023049886A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VALDES, Alexander E</creatorcontrib><creatorcontrib>VENABLE, Jennifer D</creatorcontrib><creatorcontrib>MCCARVER, Stefan</creatorcontrib><creatorcontrib>BEHENNA, Douglas C</creatorcontrib><creatorcontrib>HANNA, Luke E</creatorcontrib><creatorcontrib>GORDON, Deane</creatorcontrib><creatorcontrib>GOLDBERG, Steven D</creatorcontrib><creatorcontrib>WU, Dongpei</creatorcontrib><creatorcontrib>LOSKOT, Steven A</creatorcontrib><creatorcontrib>SHIREMAN, Brock T</creatorcontrib><creatorcontrib>MEDUNA, Steven P</creatorcontrib><creatorcontrib>XUE, Xiaohua</creatorcontrib><title>IMIDAZOPYRIDAZINE IL-17 INHIBITOR COMPOUNDS</title><description>The present application discloses compounds having the following formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, and R4 are defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.
La présente invention concerne des composés ayant la formule suivante (I) : ou des sels pharmaceutiquement acceptables de ceux-ci, R1, R2, R3 et R4 étant tels que définis dans la description, ainsi que des procédés de fabrication et d'utilisation des composés de l'invention pour traiter ou soulager un syndrome, un trouble et/ou une maladie à médiation par IL-17.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZND29PV0cYzyD4gMAtGefq4Knj66huYKnn4enk6eIf5BCs7-vgH-oX4uwTwMrGmJOcWpvFCam0HZzTXE2UM3tSA_PrW4IDE5NS-1JD7c38jAyNjAxNLCwszR0Jg4VQAZ6yYM</recordid><startdate>20230330</startdate><enddate>20230330</enddate><creator>VALDES, Alexander E</creator><creator>VENABLE, Jennifer D</creator><creator>MCCARVER, Stefan</creator><creator>BEHENNA, Douglas C</creator><creator>HANNA, Luke E</creator><creator>GORDON, Deane</creator><creator>GOLDBERG, Steven D</creator><creator>WU, Dongpei</creator><creator>LOSKOT, Steven A</creator><creator>SHIREMAN, Brock T</creator><creator>MEDUNA, Steven P</creator><creator>XUE, Xiaohua</creator><scope>EVB</scope></search><sort><creationdate>20230330</creationdate><title>IMIDAZOPYRIDAZINE IL-17 INHIBITOR COMPOUNDS</title><author>VALDES, Alexander E ; VENABLE, Jennifer D ; MCCARVER, Stefan ; BEHENNA, Douglas C ; HANNA, Luke E ; GORDON, Deane ; GOLDBERG, Steven D ; WU, Dongpei ; LOSKOT, Steven A ; SHIREMAN, Brock T ; MEDUNA, Steven P ; XUE, Xiaohua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023049886A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>VALDES, Alexander E</creatorcontrib><creatorcontrib>VENABLE, Jennifer D</creatorcontrib><creatorcontrib>MCCARVER, Stefan</creatorcontrib><creatorcontrib>BEHENNA, Douglas C</creatorcontrib><creatorcontrib>HANNA, Luke E</creatorcontrib><creatorcontrib>GORDON, Deane</creatorcontrib><creatorcontrib>GOLDBERG, Steven D</creatorcontrib><creatorcontrib>WU, Dongpei</creatorcontrib><creatorcontrib>LOSKOT, Steven A</creatorcontrib><creatorcontrib>SHIREMAN, Brock T</creatorcontrib><creatorcontrib>MEDUNA, Steven P</creatorcontrib><creatorcontrib>XUE, Xiaohua</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VALDES, Alexander E</au><au>VENABLE, Jennifer D</au><au>MCCARVER, Stefan</au><au>BEHENNA, Douglas C</au><au>HANNA, Luke E</au><au>GORDON, Deane</au><au>GOLDBERG, Steven D</au><au>WU, Dongpei</au><au>LOSKOT, Steven A</au><au>SHIREMAN, Brock T</au><au>MEDUNA, Steven P</au><au>XUE, Xiaohua</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IMIDAZOPYRIDAZINE IL-17 INHIBITOR COMPOUNDS</title><date>2023-03-30</date><risdate>2023</risdate><abstract>The present application discloses compounds having the following formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, and R4 are defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.
La présente invention concerne des composés ayant la formule suivante (I) : ou des sels pharmaceutiquement acceptables de ceux-ci, R1, R2, R3 et R4 étant tels que définis dans la description, ainsi que des procédés de fabrication et d'utilisation des composés de l'invention pour traiter ou soulager un syndrome, un trouble et/ou une maladie à médiation par IL-17.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2023049886A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | IMIDAZOPYRIDAZINE IL-17 INHIBITOR COMPOUNDS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T11%3A35%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VALDES,%20Alexander%20E&rft.date=2023-03-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023049886A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |